Regulation of apoptotic effects by erythrocarpine E, a cytotoxic limonoid from chisocheton erythrocarpus in HSC-4 human oral cancer cells

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Nagoor, Noor Hasima ^a   Shah Jehan Muttiah, Norliza ^a   Lim, Chong Soon ^a   In, Lionel L A ^a   Mohammad, Khalit ^a   Awang, Khalijah ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CHISOCHETON ERYTHROCARPUS EXTRACT; CYTOCHROME C; ERYTHROCARPINE E; FLUORESCEIN ISOTHIOCYANATE; LIMONOID; LIPOCORTIN 5; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PLANT EXTRACT; PROCASPASE 9; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

APOPTOSIS; ARTICLE; CANCER CELL; CELL PROLIFERATION; CHISOCHETON ERYTHROCARPUS; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; DOSE RESPONSE; DRUG DETERMINATION; DRUG INHIBITION; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; HUMAN CELL; MEDICINAL PLANT; MOUTH CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; CELL CULTURE; CELL STRAIN HEPG2; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; IC 50; MELIACEAE; METABOLISM; MOUTH TUMOR; PATHOLOGY; TIME; TUMOR CELL LINE; WESTERN BLOTTING;

CHISOCHETON ERYTHROCARPUS;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HEP G2 CELLS; HUMANS; INHIBITORY CONCENTRATION 50; LIMONINS; MELIACEAE; MOLECULAR STRUCTURE; MOUTH NEOPLASMS; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 80051776653     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023661     Document Type: Article

References (22)

1. Gordaliza M, (2007) Natural products as lead to anticancer drugs. Clin. Transl. Oncol 9: 767-776.
2. Hasima N, In LLA, Azmi MN, Nazif AA, Eswary T, et al. (2010) 1′S-1′-Acetoxyeugenol acetate: A new chemotherapeutic natural compound against MCF-7 human breast cancer cells. Phytomedicine 17: 935-939.
3. da Rocha AB, Lopes RM, Schwartsmann G, (2001) Natural products in anticancer therapy. Curr Opin Pharmacol 1: 364-369.
4. Ozaki Y, Ayano S, Inaba N, Miyake M, Berhow MA, et al. (1995) Limonoid glucosides in fruit, juice and processing by-products of Satsuma Mandarin (Citrus unshiu Marcov.). J Food Sci 60: 186-189.
5. Lam LKT, Zhang J, Hasegawa S, (1994) Citrus limonoid reduction of chemically induced tumorigenesis. Food Technology, 48: 104-108.
6. Tanaka T, Kohno H, Kawaqbata K, Honjo S, Miyake M, et al. (2000) Citrus limonoids obacunone and limonin inhibit the development of a precursor lesion, aberrant crypt foci for colon cancer in rats. In: Citrus Limonoids: Functional Chemicals in Agriculture and Foods. ACS Symposium 758: 145-163.
7. Guthrie N, Hasegawa S, Manners G, Vandenberg T, (2000) Inhibition of human breast cancer cells by citrus limonoids. In: Citrus Limonoids: Functional Chemicals in Agriculture and Food. ACS Symposium 758: 164-174.
8. Kumar S, Suresh PK, Vijayababu MR, Arunkumar A, Arunakaran J, (2006) Anticancer effects of ethanolic neem leaf extract on prostate cancer cell line (PC-3). Journal of Ethnopharmacology 105: 246-250.
9. de Bruin EC, Medema JP, (2008) Apoptosis and non-apoptotic deaths in cancer development and treatment response. Cancer Treatment Reviews doi:10.1016/j.ctrv.2008.07.001.
10. Patil JR, Jayaprakasha GK, Murthy KNC, Tichy SE, Chetti MB, et al. (2009) Apoptosis-mediated proliferation inhibition of human colon cancer cells by volatile principles of Citrus aurantifolia. Food Chemistry 114: 1351-1358.
11. Awang K, Lim CL, Mohamad K, Morita H, Hirasawa Y, et al. (2007) Erythrocarpines A-E, new cytotoxic limonoids from Chisocheton erythrocarpus. Biorganic & Medicinal Chemistry 15: 5997-6002.
12. Bursztajn S, Feng JJ, Berman SA, Nanda A, (2000) Poly (ADP-ribose) polymerase induction is an early signal of apoptosis in human neuroblastoma. Molecular Brain Research 76: 363-376.
13. Jessie L, Au S, Wientjes MG, (1999) Kinetics of hallmark biochemical changes in Paclitaxel-induced apoptosis. AAPS Pharmsci 1: 1-8.
14. Vakkila J, Lotze MT, (2004) Inflammation and necrosis promote tumour growth.Nat Rev Immunol 4: 641-48.
15. Tolis C, Peters GJ, Ferreira CG, Pinedo HM, Giaccone G, (1999) Cell Cycle Disturbances and Apoptosis Induced by Topotecan and Gemcitabine on Human Lung Cancer Cell Lines. European Journal of Cancer 35 (5): 796-807.
16. Haupt S, Berger M, Goldberg Z, Haupt Y, (2003) Apoptosis- the p53 network. Journal of Cell Science 116: 4077-4085.
17. Hollstein M, Sidransky D, Vogelstein B, Harris CC, (1991) p53 mutations in human cancers. Science 253 (5015): 49-53.
18. Matsumoto H, Wada T, Fukunaga K, Yoshihiro S, Matsuyama H, et al. (2004) Bax to Bcl-2 Ratio and Ki-67 Index are Useful Predictors of Neoadjuvant Chemoradiation Therapy in Bladder Cancer. Japanese Journal of Clinical Oncology 34: 124-130.
19. Hsu YT, Wolter KG, Youle RJ, (1997) Cytosol-to-membrane redistribution of Bax and Bcl-XL during apoptosis. Proc Natl Acad Sci USA 94 (8): 3668-3672.
20. Patil JR, Jayaprakasha GK, Murthy KNC, Chetti MB, Patil BS, (2010) Characterization of Citrus aurantifolia bioactive compounds and their inhibition of human pancreatic cancer cells through apoptosis. Microchemical Journal 94 (2): 108-117.
21. Gewies A, (2003) Introduction to Apoptosis. ApoReview 1-263.
22. Zhao JF, Sun AH, Ruan P, Zhao XH, Lu MQ, et al. (2009) Vibrio vulnificus cytolysin induces apoptosis in HUVEC, SGC-7901 and SMMC-7721 cells via caspase-9/3-dependent pathway. Microbial Pathogenesis 46: 194-200.